Viromed Medical AG (Q11) — Financial Flexibility Index
Viromed Medical AG (Q11) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of €10.10 Million (operating CF €-10.12 Million minus capex €20.22 Million) represents 0% of total liabilities (€69.84 Million). Also explore Q11 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Viromed Medical AG Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Viromed Medical AG across 4 annual periods. Check how strategically is Viromed Medical AG's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Viromed Medical AG (2021–2024)
Year-by-year free cash flow to debt coverage for Viromed Medical AG. For the full company profile including market capitalisation, see Q11 market cap overview.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | €105.40 Million | €-6.03 Million | €54.82 Million | ▲ +938.3% |
| 2023 | -0.23x | €-9.85 Million | €-34.16 Million | €42.96 Million | ▲ +97.9% |
| 2022 | -11.00x | €-20.55 Million | €-20.87 Million | €1.87 Million | ▼ -197.1% |
| 2021 | -3.70x | €-10.41 Million | €-22.29 Million | €2.81 Million | — |